IMP-68, a Novel IMP-Type Metallo-β-Lactamase in Imipenem-Susceptible Klebsiella pneumoniae

Author:

Kubota Hiroaki1ORCID,Suzuki Yasunori1ORCID,Okuno Rumi1,Uchitani Yumi1,Ariyoshi Tsukasa1ORCID,Takemura Nobuyuki2ORCID,Mihara Fuminori2,Mezaki Kazuhisa3,Ohmagari Norio4ORCID,Matsui Mari5ORCID,Suzuki Satowa5ORCID,Sekizuka Tsuyoshi6ORCID,Kuroda Makoto6ORCID,Yokoyama Keiko1,Sadamasu Kenji1ORCID

Affiliation:

1. Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan

2. Department of Hepato-Biliary Pancreatic Surgery, National Center for Global Health and Medicine, Tokyo, Japan

3. Microbiology Laboratory, National Center for Global Health and Medicine, Tokyo, Japan

4. Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan

5. Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan

6. Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan

Abstract

IMP-type metallo-β-lactamases comprise one group of the “Big 5” carbapenemases. Here, a novel bla IMP-68 gene encoding IMP-68 (harboring a Ser262Gly point mutant of IMP-11) was discovered from meropenem-resistant but imipenem-susceptible Klebsiella pneumoniae TA6363. The Ser262Gly substitution was previously identified as important for substrate specificity according to a study of other IMP variants, including IMP-6. We confirmed that IMP-68 exhibited weaker imipenem-hydrolyzing activity than that for other carbapenems, demonstrating that the antimicrobial susceptibility profile of TA6363 originated from IMP-68 substrate specificity, with this likely to affect treatment strategies using antibacterial agents in clinical settings. Notably, the carbapenem resistance conferred by IMP-68 was undetectable based on the MIC of imipenem as a carbapenem representative, which demonstrates a comparable antimicrobial susceptibility profile to IMP-6-producing Enterobacteriaceae that previously spread in Japan due to lack of awareness of its existence.

Funder

Ministry of Health, Labour and Welfare

Japan Agency for Medical Research and Development

Publisher

American Society for Microbiology

Subject

Molecular Biology,Microbiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3